Canada markets closed

Affluent Medical SA (0JZ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.6300+0.0050 (+0.31%)
At close: 03:29PM CET

Affluent Medical SA

320, avenue Archimède
Les Pléiades III – Bâtiment B
Aix-en-Provence 13100
France
33 4 42 95 12 20
https://www.affluentmedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees52

Key Executives

NameTitlePayExercisedYear Born
Sebastien Ladet Ph.D.Chief Executive OfficerN/AN/AN/A
Christophe de VregilleChief Financial OfficerN/AN/AN/A
Ms. Celine BuardMarketing DirectorN/AN/AN/A
Melanie CantalHuman Resources ManagerN/AN/AN/A
Prof. Francois Laborde M.D., Ph.D.Chief Surgical OfficerN/AN/AN/A
Mr. Olivier PierronDeputy Chief Executive OfficerN/AN/A1969
Benjamin Renault Ph.D.Chief Development OfficerN/AN/AN/A
Dr. Christophe Giot M.D.Chief Medical Officer & VP of Clinical AffairsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

Corporate Governance

Affluent Medical SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.